男性膀胱过度活动症的尿动力学分型及临床疗效随访

doi:10.19723/j.issn.1671-167X.2019.06.012

Abstract

Abstract:

Objective: To introduce a urodynamic classification of male patients with symptoms of overactive bladder (OAB) and discuss its clinical significance in practice.Methods: From January 2015 to January 2017, there were 181 male patients from Peking University People’s Hospital who were diagnosed clinically with OAB and underwent preoperative urodynamic test. Finally 126 male patients were enrolled in the research. Male OAB patients could be stratified into four groups based on the chief complaints (whether or not presenting urgency) and the results of urodynamic test (whether or not presenting detrusor overactivity and the ability to stop the involuntary contraction). The contents of this follow-up study included the basic information, the preoperative and postoperative scores of the OAB symptom score (OABSS), the preoperative and postoperative scores of the international prostate symptom score (IPSS), and the amount of the concomitant diseases.Results: According to the classification, the amounts of the four types of OAB patients were 32 (25.40%) for type Ⅰ, 27 (21.43%) for type Ⅱ, 59 (46.83%) for type Ⅲ, and 8 (6.35%) for type Ⅳ, respectively. The data of their heights showed no statistical significance (P>0.05). The ages, weights and the amount of the concomitant diseases of type Ⅳ were obviously higher than those of the other three types (P<0.05). And the ages, weights and the amount of the concomitant diseases of the other three types had shown no statistical significance (P>0.05). The improvement of the OABSS and IPSS scores of the type Ⅳ were obviously inferior to the other three types (P<0.05). The improvements of the OABSS and IPSS scores of type Ⅲ were obviously higher than those of the other three (P<0.05). The discrepancy of the OABSS and IPSS scores of type Ⅰ and type Ⅱ had shown no statistical significance (P>0.05).Conclusion: Type Ⅳ has the worst outcome and type Ⅲ has the best among the four types of OAB. And this classification system will certainly have a profound significance in guiding and directing our clinical diagnosis and treatments, and evaluating the prognosis of the patients with OAB.

Key words: Male, Overactive bladder, Urination disorders, Urodynamics

CLC Number:

R694

Tao WANG,Ke-xin XU,Wei-yu ZHANG,Hao HU,Xiao-wei ZHANG,Huan-rui WANG,Xian-hui LIU,Jing-wen CHEN,Xiao-peng ZHANG. Urodynamic classification of male patients with symptoms of overactive bladder and the outcome classification[J].Journal of Peking University(Health Sciences), 2019, 51(6): 1048-1051.

Figures/Tables 4

Table 1

Figure 1

Table 2

Univeriate analysis of information about the four types of male OAB patients"

Variables	Type Ⅰ	Type Ⅱ	Type Ⅲ	Type Ⅳ	Univariate analysis (P values)
Age/years, $x ?$ ±s	69.50±13.92	69.51±8.05	68.75±9.29	78.50±9.20	0.033
Height/cm, $x ?$ ±s	171.38±5.98	171.70±6.00	171.22±5.54	173.63±4.94	0.125
Weight/kg, $x ?$ ±s	69.30±6.19	68.43±5.68	68.93±8.83	73.50±7.52	0.030
OABSS^*, $x ?$ ±s	4.62±2.23	4.18±2.45	6.07±3.33	2.75±1.77	<0.001
IPSS^*, $x ?$ ±s	14.72±6.71	14.26±8.00	16.13±8.25	7.45±4.70	0.036
Concomitant disease, $x ?$ ±s	2.25±1.11	2.22±1.09	2.16±1.15	4.25±2.60	<0.001

Table 2

Table 3

References 15

[1]	Abrams P, Cardoz L, Fall M , et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society[J]. Neurourol Urodyn, 2002,21(2):167-178.
[2]	Kurosch M, Mager R, Gust K , et al. Diagnosis of overactive bladder (OAB)[J]. Urologe A, 2015,54(3):421-427.
[3]	Chen SL, Ng SC, Huang YH, Chen GD . Are patients with bladder oversensitivity different from those with urodynamically proven detrusor overactivity in female overactive bladder syndrome?[J]. J Chin Med Assoc, 2017,80(10):644-650.
[4]	D’Ancona CA, Bassani JW, Querne FA , et al. New method for minimally invasive urodynamic assessment in men with lower urinary tract symptoms[J]. Urology, 2008,71(1):75-78.
[5]	Flisser AJ, Walmsley K, Blaivas JG . Urodynamic classification of patients with symptoms of overactive bladder[J]. J Urol, 2003,169(2):529-533.
[6]	Fall M, Geirsson G, Lindstrom S . Toward a new classification of overactive bladders[J]. Neurourol Urodyn, 1995,14(6):635-646.
[7]	Yamaguchi O, Nishizawa O, Takeda M , et al. Clinical guidelines for overactive bladder[J]. Int J Urol, 2009,16(2):126-142.
[8]	Höfner K . Terminology and pathophysiology of overactive bladder (OAB)[J]. Aktuelle Urol, 2016,47(6):468-474.
[9]	Daly D, Chapple C . Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology?[J]. BJU Int, 2013,111(4):530-531.
[10]	Vahabi B, Drake MJ . Physiological and pathophysiological implications of micromotion activity in urinary bladder function[J]. Acta Physiol (Oxf), 2015,213(2):360-370.
[11]	Bothig R, Domurath B, Kaufmann A , et al. Neuro-urological diagnosis and therapy of lower urinary tract dysfunction in patients with spinal cord injury: S2k Guideline of the German-Speaking Medical Society of Paraplegia (DMGP)[J]. Urologe A, 2017,56(6):785-792.
[12]	Mehnert U, Nehiba M . Neuro-urological dysfunction of the lower urinary tract in CNS diseases: pathophysiology, epidemiology, and treatment options[J]. Urologe A, 2012,51(2):189-197.
[13]	Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK , et al. Real-time changes in brain activity during sacral neuromodulation for overactive bladder[J]. J Urol, 2017,198(6):1379-1385.
[14]	Sakakibara R, Panicker J, Fowler CJ , et al. Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly[J]. Int J Urol, 2014,21(1):33-38.
[15]	Elser DM . Stress urinary incontinence and overactive bladder syndrome: current options and new targets for management[J]. Postgrad Med, 2012,124(3):42-49.

Related Articles 15

[1]	Ruilin GUO, Lei ZHANG, Yu WANG, Xiaoqing WANG, Xiaoxiao WANG, Songwen NIAN, Lihui ZHANG, Bingbing XIAO, Ye LU. Effect of TVT-Abbrevo in the treatment of female stress urinary incontinence [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 337-341.
[2]	Yuanjie NIU, Zhongcheng XIN, Guiting LIN, Pan DING, Jiancheng PAN, Yuhong FENG, Yinglu GUO. Low-level laser therapy for the treatment of male infertility and erectile dysfunction [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 627-632.
[3]	Qi WANG, Hanwei KE, Zehua DING, Weiyu ZHANG, Xiaopeng ZHANG, Tao XU, Kexin XU. Effects of retropubic and obturator urethral suspension on postoperative maximum flow rate and residual urine volume [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 717-720.
[4]	Xin CHEN, Junting YANG, Jinxin GUO, Shuya LI, Zhike LIU, Yingliang ZHU, Fengjuan LI, Siyan ZHAN, Juanjuan GUO. Prevalence characteristics of autoimmune thyroid disease in women aged 10-59 years in Qingdao City from 2022 to 2024 [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 507-513.
[5]	Ning LIU, Libo MAN, Feng HE, Guanglin HUANG, Jianpo ZHAI. Correlation between urination intermittences and urodynamic parameters in benign prostatic hyperplasia patients [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 328-333.
[6]	Hanwei KE, Qi WANG, Kexin XU. Optimization study of an animal model for interstitial cystitis/bladder pain syndrome based on the dose effect of cyclophosphamide [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 908-912.
[7]	Ye YAN,Xiaolong LI,Haizhui XIA,Xuehua ZHU,Yuting ZHANG,Fan ZHANG,Ke LIU,Cheng LIU,Lulin MA. Analysis of risk factors for long-term overactive bladder after radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 589-593.
[8]	Yuqing LI,Biao WANG,Peng QIAO,Wei WANG,Xing GUAN. Medium to long-term efficacy of tension-free vaginal tape procedure in the treatment of female recurrent stress urinary incontinence [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 600-604.
[9]	Yifan WU,Yingxiang YU,Lan XIE,Zhida ZHANG,Cuiqing CHANG. Characteristics of resting energy expenditure and evaluation of prediction formulas in young men with different body mass indexes [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 247-252.
[10]	Zi-kai WANG,Jia-li MO,Meng ZHANG,Ji-ping LIAO. Epidemiology and hospitalization costs analysis of female inpatients with acute exacerbation of chronic obstructive pulmonary disease in Beijing from 2013 to 2020 [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1074-1081.
[11]	Xue-zhao JI,Shan LIU,Wan-zhou WANG,Ye-tong ZHAO,Lu-yi LI,Wen-lou ZHANG,Guo-feng SHEN,Fu-rong DENG,Xin-biao GUO. Associations between indoor volatile organic compounds and nocturnal heart rate variability of young female adults: A panel study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 488-494.
[12]	Hao LIN,Jing-hua LI,Xiao YANG,Xiao-ting CHEN,Yu-hui SHI,Chun CHANG,Yuan-tao HAO,Wang-nan CAO. Discrepancy between behavioral-indicated and perceived candidacy for HIV pre-exposure prophylaxis among men who have sex with men in Chengdu, China [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 511-520.
[13]	Xi-ya SUN,Yi-lu CHEN,Lin ZENG,Li-ying YAN,Jie QIAO,Rong LI,Xu ZHI. Correlation analysis of vitamin D level and anti-Müllerian hormone in infertile female and the role in predicting pregnancy outcome [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 167-173.
[14]	Lin ZHU,Wei-yu ZHANG,Ke-xin XU. Urodynamic and histological evaluation of cyclophosphamide-induced bladder pain syndrome in SD rats [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 735-740.
[15]	DU Qiang,HONG Kai,PAN Bo-chen. Comparison of two methods for detection of Chlamydia trachomatis and Ureaplasma urealyticum in male reproductive tract [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 785-788.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 0

No Suggested Reading articles found!

Types	Symptoms	Urodynamic test
Type Ⅰ	Urgency, no incontinence	No DO, no incontinence
Type Ⅱ	Urgency, no incontinence	DO, no incontinence
Type Ⅲ	Urgency, incontinence	DO, incontinence
Type Ⅳ	No urgency, incontinence	DO, incontinence

Variables	OR	95%CI	P values
Age	1.76	1.10-4.21	0.036
Weight	1.99	1.21-3.09	0.039
OABSS^*	3.55	1.57-8.23	0.014
IPSS^*	1.37	1.04-4.25	0.045
Concomitant disease	2.98	2.01-7.36	0.016

Urodynamic classification of male patients with symptoms of overactive bladder and the outcome classification

RICH HTML

PDF (PC)